Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer.
Yokomizo A, Kanimoto Y, Okamura T, Ozono S, Koga H, Iwamura M, Tanaka H, Takahashi S, Tsushima T, Kanayama HO, Akaza H, Shinohara N, Mugiya S, Nomata K, Nakamura T, Naito S. Yokomizo A, et al. Among authors: akaza h. J Urol. 2016 Jan;195(1):41-6. doi: 10.1016/j.juro.2015.08.075. Epub 2015 Aug 22. J Urol. 2016. PMID: 26307162 Clinical Trial.
Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
Hinotsu S, Akaza H, Isaka S, Kanetake H, Kubota Y, Kuroda M, Shinohara N, Shinka T, Tachibana M, Naito S, Hirao Y; BCG Tokyo 172 Strain Study Group. Hinotsu S, et al. Among authors: akaza h. Urology. 2006 Mar;67(3):545-9. doi: 10.1016/j.urology.2005.09.045. Urology. 2006. PMID: 16527576 Clinical Trial.
Maintenance intravesical bacillus Calmette-Guérin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group.
Koga H, Ozono S, Tsushima T, Tomita K, Horiguchi Y, Usami M, Hirao Y, Akaza H, Naito S; BCG Tokyo Strain Study Group. Koga H, et al. Among authors: akaza h. Int J Urol. 2010 Sep;17(9):759-66. doi: 10.1111/j.1442-2042.2010.02584.x. Epub 2010 Jul 4. Int J Urol. 2010. PMID: 20604814 Clinical Trial.
Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer.
Hinotsu S, Akaza H, Naito S, Ozono S, Sumiyoshi Y, Noguchi S, Yamaguchi A, Nagamori S, Terai A, Nasu Y, Kume H, Tomita Y, Tanaka Y, Samma S, Uemura H, Koga H, Tsushima T. Hinotsu S, et al. Among authors: akaza h. BJU Int. 2011 Jul;108(2):187-95. doi: 10.1111/j.1464-410X.2010.09891.x. Epub 2010 Dec 22. BJU Int. 2011. PMID: 21176079 Clinical Trial.
Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association.
Hinotsu S, Akaza H, Miki T, Fujimoto H, Shinohara N, Kikuchi E, Mizutani Y, Koga H, Okajima E, Okuyama A; Japanese Urological Association. Hinotsu S, et al. Among authors: akaza h. Int J Urol. 2009 Jan;16(1):64-9. doi: 10.1111/j.1442-2042.2008.02194.x. Epub 2008 Nov 27. Int J Urol. 2009. PMID: 19054170
A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: insights into the treatment, efficacy and safety.
Uemura H, Shinohara N, Yuasa T, Tomita Y, Fujimoto H, Niwakawa M, Mugiya S, Miki T, Nonomura N, Takahashi M, Hasegawa Y, Agata N, Houk B, Naito S, Akaza H. Uemura H, et al. Among authors: akaza h. Jpn J Clin Oncol. 2010 Mar;40(3):194-202. doi: 10.1093/jjco/hyp146. Epub 2009 Nov 7. Jpn J Clin Oncol. 2010. PMID: 19897852 Clinical Trial.
638 results